Survey Finds 80 Pct of U.S. Doctors Witness Mistakes
Jan 26, 2005
Eighty percent of U.S. doctors and half of nurses surveyed said they had seen colleagues make mistakes, but only 10 percent ever spoke up, according to a study released on Wednesday.

WHO: Disease Outbreak Still Risk in Indonesia's Aceh
Jan 25, 2005
Survivors of last month's quake and tsunami in Indonesia still face the risk of deadly disease outbreaks such as cholera, but epidemics could be controlled, a senior U.N. official said on Tuesday.

Obesity May Affect Prostate Screening, Study Finds
Jan 24, 2005
Obese men may get falsely reassuring results on prostate cancer screening tests, U.S. researchers said on Monday.

Lung Cancer Is a Woman's Disease
Jan 23, 2005
Think lung cancer, and most people picture a disease that primarily strikes older men who smoke.

FDA Delays Nonprescription Morning-After Pill Rule
Jan 22, 2005
U.S. regulators on Friday delayed a decision on whether to approve over-the-counter sales of a Barr Pharmaceuticals "morning-after pill" to prevent pregnancy, prompting a lawsuit from a women's rights group.

'Morning After' Treatment Advised to Prevent AIDS
Jan 21, 2005
A "morning after" treatment for the AIDS virus can help prevent infection after a rape, contact with a contaminated needle or even a night of passion without a condom, U.S. health officials said on Thursday.

Daily Drink Improves Thinking in Older Women -Study
Jan 20, 2005
Women who enjoy a drink of beer or wine daily have sharper minds into old age than women who abstain, U.S. researchers reported on Wednesday.

More Evidence Found of Painkiller Heart Risks
Jan 17, 2005
More evidence of how painkillers called COX-2 inhibitors can raise the risk of heart disease was published Monday, showing Pfizer Inc.'s Bextra can triple the risk of heart attack and stroke in certain patients.

Women's Groups Pressure FDA on 'Morning-After' Pill
Jan 16, 2005
Women's rights groups seeking easier access to emergency contraception are pressuring U.S. regulators as they try to decide whether to approve a non-prescription "morning-after" pill.

FDA Panel Rejects Merck OTC Drug
Jan 15, 2005
A U.S. advisory panel on Friday urged regulators to reject over-the-counter sales of Merck & Co. Inc.'s cholesterol-lowering drug Mevacor because of doubts the medicine could be used safely without a doctor's guidance.